Prognose

70 Produkte

    70 Produkte
    Immunotherapy in breast cancer. Immunotherapy is not a magic treatment. 11
    CHF 0.00
    Breast cancer treatment. How to select neoadjuvant and adjuvant chemotherapy? 10
    CHF 0.00
    When can breast cancer be considered cured? Is cure possible for breast cancer? 5
    CHF 0.00
    Esophageal cancer treatment FAQ. Prognosis. When surgery is not beneficial? 11
    CHF 0.00
    How to select drug combinations for multiple myeloma treatment? 7
    CHF 0.00
    Multiple myeloma. Patient’s story: elderly woman and ‘last hope’ CAR T-cell therapy. 13
    CHF 0.00
    Multiple myeloma. FAQ: Immunization, Vitamin D and bone health, quality of life. 12
    CHF 0.00
    Future in multiple myeloma treatment. When will it be a ‘curable disease’? 11
    CHF 0.00
    Castleman Disease. Subtypes and treatment options. 10
    CHF 0.00
    Multiple myeloma. Minimal Residual Disease evaluation. Prognosis. 9
    CHF 0.00
    Multiple myeloma. Progress and challenges of treatment. 1
    CHF 0.00
    FAQ from patients with fatty liver disease. Life quality, prognosis, alcohol use. 15
    CHF 0.00
    Liver cancer risk and fatty liver disease. Cancer screening in NASH, NAFLD. 10
    CHF 0.00
    How NASH differs from NAFLD. What drives progression to NASH? 5
    CHF 0.00
    Can fatty liver disease be reversed? NAFLD and NASH treatment. 4
    CHF 0.00
    Pediatric arthritis FAQ. Can a child with arthritis lead a normal life? 16
    CHF 0.00
    Arthritis in children. FAQ. Nutrition in arthritis. Will my child outgrow arthritis? 15
    CHF 0.00
    Multisystem inflammatory syndrome in children. MIS-C. Prognosis and recovery. 3
    CHF 0.00
    Mesothelioma. Clinical case. Example of importance of enrollment into clinical trials. 11
    CHF 0.00
    Mesothelioma. Importance 
for patients of enrollment into clinical trials. 10
    CHF 0.00
    Future in mesothelioma treatment. 9
    CHF 0.00
    Mesothelioma. Surgical treatment options. 4
    CHF 0.00
    Koronararterien-Calcium-Score. Bester universeller Prädiktor für Herzerkrankungen? 9
    CHF 0.00
    Wie bereitet man sich auf eine Wirbelsäulenoperation vor? 8
    CHF 0.00
    Multiple Sklerose. Angeborenes und adaptives Immunsystem interagieren. 3
    CHF 0.00
    Klinischer Fall. Tennisspieler mit gesperrtem Knie. Osteochondritis dissecans (OCD). 9
    CHF 0.00
    Jeder Krebspatient muss vom Tumor Board evaluiert werden. Multidisziplinäres Team. 9-2
    CHF 0.00
    Prognose Darmkrebs. Adaptive klinische Studien. Vorhersage des Ansprechens auf die Behandlung. 8-1
    CHF 0.00
    Chemotherapie des Rektumkarzinoms. Capecitabin (Xeloda) und Oxaliplatin 5-FU. Kontroversen. 5-3
    CHF 0.00
    Operationsmöglichkeiten bei Dickdarmkrebs. Beste Therapie bei Darmkrebs. 8
    CHF 0.00
    Myeloproliferative Störung. Diagnose und Behandlung. 4
    CHF 0.00
    Myelodysplastisches Syndrom. Behandlung und Prognose. 3
    CHF 0.00
    Zuletzt Angesehen